Clinical Trials Directory

Trials / Unknown

UnknownNCT04314232

Mechanisms for Covid-19 Disease Complications

Changes in Organ Specific Biomarkers, Virus Expression and Prognosis of Covid-19

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
University Hospital, Akershus · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Covid-19 is associated with a wide range of symptoms and clinical trajectories, and early identification of patients at risk for developing severe disease is desirable. Several risk markers and comorbidity profiles have been proposed but their relative importance in unselected patients admitted to hospital with Covid-19 remains unclear. This study aims to assess the prognostic value organ specific biomarkers, viral dynamics and immune response markers in patients infected with SARS-CoV2.

Conditions

Timeline

Start date
2020-03-18
Primary completion
2021-12-31
Completion
2021-12-31
First posted
2020-03-19
Last updated
2020-06-26

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT04314232. Inclusion in this directory is not an endorsement.

Mechanisms for Covid-19 Disease Complications (NCT04314232) · Clinical Trials Directory